Anticancer immunity targeting therapy (IMAGE)

Stowers Institute for Medical Research

Anticancer immunity targeting therapy

Caption

Anticancer immunity targeting therapy-resistant leukemia stem cells is activated by low-dose doxorubicin.

Credit

Image/Art credit: Mark Miller, Stowers Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.